CGP-45688
CGP-45688 is an orally active non-steroidal aromatase inhibitor with an ED50 of 30-100 μg/kg. CGP-45688 can reduce the level of estrogen in the body, thereby inhibiting the growth of estrogen-dependent tumors. CGP-45688 inhibits the growth of estrogen-dependent breast tumors in rat models. CGP-45688 disrupts the ovarian cycle and inhibits the weight of the uterus. CGP-45688 can be used for the study of breast cancer[1].
Product Specifications
CAS Number
134520-88-0
UNSPSC
12352005
Target
Cytochrome P450
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
N#CC1=CC=C(C(C2=CC=C(C=C2)C#N)N3N=CN=N3)C=C1
Molecular Formula
C16H10N6
Molecular Weight
286.29
References & Citations
[1]Schieweck K, et al. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. J Steroid Biochem Mol Biol. 1993 Mar;44 (4-6) :633-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1017627-01 0.02 mg (E-Coli)
Recombinant Arabidopsis thaliana Probable pectinesterase/pectinesterase inhibitor 39 (PME39)
Sign In for Pricing
View Details